about
Zika virus complete genome from Salvador, Bahia, BrazilIdentifying Recent HIV Infections: From Serological Assays to GenomicsConcentrated HIV subepidemics in generalized epidemic settingsA standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequencesSpread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling studyExtensive HIV-1 intra-host recombination is common in tissues with abnormal histopathologyModeling HIV-1 drug resistance as episodic directional selectionTrends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment RegimensHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaHIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South AfricaGenome-Wide Association Study of HIV Whole Genome Sequences Validated using Drug ResistanceHistory and origin of the HIV-1 subtype C epidemic in South Africa and the greater southern African regionDifferent epidemic potentials of the HIV-1B and C subtypes.Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.RegaDB: community-driven data management and analysis for infectious diseasesAn automated genotyping system for analysis of HIV-1 and other microbial sequences.High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania.The HIV-1 subtype C epidemic in South America is linked to the United Kingdom.Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.Evolution and molecular epidemiology of subtype C HIV-1 in ZimbabweThe HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries.Primary drug resistance in South Africa: data from 10 years of surveys.Detection of transmission clusters of HIV-1 subtype C over a 21-year period in Cape Town, South AfricaMapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.Evidence of long-lived founder virus in mother-to-child HIV transmission.Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes A, B, G and unique recombinant AC and AD viral strains identified in South Africa.The Development of Computational Biology in South Africa: Successes Achieved and Lessons Learnt.Understanding Specific Contexts of Antiretroviral Therapy Adherence in Rural South Africa: A Thematic Analysis of Digital Stories from a Community with High HIV Prevalence.Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children.Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in BotswanaPhylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1.Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequencesDevelopment and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots.
P50
Q23906890-B6F1EA8A-AF01-433F-8D4C-F08D863B0D5BQ26778001-CA525246-9A7F-45DD-A6D2-E746E66A13C1Q27023461-4BBDD85F-A51D-4DCF-B4E0-F5971254F989Q27488863-A5EEA72F-0997-409D-9A08-F42837DAFFB8Q28119353-47796F28-CA99-4B0E-A3E3-5077275ADB93Q28475143-5E2998DE-42B6-49F1-93F5-7B421D72328BQ28483642-EF62AE56-F865-4B45-B816-C504E90A26C7Q28534323-4C77915F-04C2-4760-A546-8E4D5954B1C6Q28535483-A8B8E781-8368-42BE-A593-BB907A5156D9Q28540635-50A53579-272B-4C9B-8D4E-EC715DBE4154Q28554356-6E99993B-A0BD-497D-BF8E-2EF644F9C997Q28607391-44DB1EF3-73F8-4575-B841-BA29A6C9E8CAQ30011040-3977B0E0-5081-4294-AC5D-37F865E85026Q30376421-BEA54343-5D47-4645-A5D2-C778EF91E009Q30621161-5013DDCC-B172-494C-894D-7683C02AD75EQ33220974-7C7F55F8-2488-48DC-AA92-C80EB2030EA1Q33312946-576F6C7B-0C4E-47CE-8332-B74E1BA4AF0BQ33533291-B3D299BF-8996-4501-8C01-C0C04590AF80Q33603586-30897DF3-D4CC-498A-BD24-5E1E277BEFF6Q33647567-C6F2D1EA-C0B7-4F64-A5E5-7081BDF45D10Q33712438-C41CC251-717B-4543-A60A-B33027B4158DQ33851789-C93D8F83-870A-402C-A3EA-4C15797C2ED5Q34073190-6B8119FD-4AA9-4897-9495-8ABF13E995E8Q34080833-143C6D46-353D-4527-9B10-F8C50D844018Q34129300-B3A02E84-1D1E-4B7E-9504-AA3961C3E8C1Q34428077-1832F3BB-1F55-476E-9D5C-72DB18B3C255Q34645213-0B775114-359F-4F16-8BA7-F8651634FAF9Q35006672-92459D51-90D1-47B4-88FB-58C68DF8223FQ35114102-5BB8497D-8023-4934-841C-91AF8BCF03D5Q35203401-CDBC4FC8-9062-4F52-BAFD-4F0834ACC942Q35230103-45E8FB09-B8E8-4D61-9381-488FC9AB89A1Q35914368-037AF9D4-226E-4638-96A6-F073E60D54FAQ35940246-AF1DDEA6-2FA2-4940-94CD-BD51CC675228Q36078446-09D7ED91-EC43-4A46-801D-3C92289F4FBAQ36110367-D55D10E1-B1B3-4EFE-B6A0-BF0CFEE537C1Q36315774-0C8DE9EE-8614-4BEE-8121-07AE8F9CFF82Q36619830-BEB9EEE1-4001-448C-9092-4BC82A144E96Q36845949-A4DB3E94-0902-4160-9F79-0B067B185CCDQ37026352-9DFF8323-B2F7-4EA8-9AAE-D544ACEA96F9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tulio de Oliveira
@ast
Tulio de Oliveira
@en
Tulio de Oliveira
@es
Tulio de Oliveira
@nl
Tulio de Oliveira
@sl
type
label
Tulio de Oliveira
@ast
Tulio de Oliveira
@en
Tulio de Oliveira
@es
Tulio de Oliveira
@nl
Tulio de Oliveira
@sl
prefLabel
Tulio de Oliveira
@ast
Tulio de Oliveira
@en
Tulio de Oliveira
@es
Tulio de Oliveira
@nl
Tulio de Oliveira
@sl